Nanoparticles based on natural, engineered or synthetic proteins and polypeptides for drug delivery applications.

International Journal of Pharmaceutics
Evangelos GeorgilisElisabeth Garanger

Abstract

Medicine formulations at the nanoscale, referred to as nanomedicines, have managed to overcome key challenges encountered during the development of new medical treatments and entered clinical practice, but considerable improvement in terms of local efficacy and reduced toxicity still need to be achieved. Currently, the fourth-generation of nanomedicines is being developed, employing biocompatible nanocarriers that are targeted, multifunctional, and stimuli-responsive. Proteins and polypeptides can fit the standards of an efficient nanovector because of their biodegradability, intrinsic bioactivity, chemical reactivity, stimuli-responsiveness, and ability to participate in complex supramolecular assemblies. These biomacromolecules can be obtained from natural resources, produced in heterologous hosts, or chemically synthesized, allowing for different designs to access suitable carriers for a variety of drugs. To enhance targeting or therapeutic functionality, additional chemical modifications can be applied. This review demonstrates the potential of polypeptide and protein materials for the design of drug delivery nanocarriers with a special focus on their preclinical evaluation in vitro and in vivo.

References

Nov 4, 1977·European Journal of Pediatrics·K KasperekH J Bremer
Sep 21, 2002·Chemical Communications : Chem Comm·J C van Hest, D A Tirrell
May 14, 2003·Biomacromolecules·Ashish NagarsekarHamidreza Ghandehari
Sep 19, 2003·Trends in Microbiology·Rob Noad, Polly Roy
May 11, 2004·Biomacromolecules·Ung-Jin KimDavid L Kaplan
Feb 17, 2005·Journal of the American Chemical Society·Juan Rodríguez-Hernández, Sébastien Lecommandoux
Sep 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William J GradisharJoyce O'Shaughnessy
Sep 22, 2006·Journal of Virology·Jiansong XieSarah F Hamm-Alvarez
Feb 6, 2007·Biophysical Journal·Thierry LefèvreMichel Pézolet
Feb 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mitsunobu R KanoKohei Miyazono
May 4, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mayank D Bhavsar, Mansoor M Amiji
Sep 18, 2007·Nature Biotechnology·Christian WolfrumMarkus Stoffel
Mar 14, 2008·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Amandeep KaurAshok K Tiwary
Sep 2, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·S Puthli, P Vavia
Oct 23, 2008·Nano Letters·David P CormodeWillem J M Mulder
Feb 13, 2009·Angewandte Chemie·Markus HeimThomas Scheibel
Jun 16, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michiaki KumagaiKazunori Kataoka
Jun 23, 2009·Recent Patents on Anti-cancer Drug Discovery·Qiang FuZhonggui He
Jul 3, 2009·Small·Aihui MahamYuehe Lin
Jul 14, 2010·Advances in Protein Chemistry and Structural Biology·Anna Mitraki
Aug 11, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoshiko UesugiYasuhiko Tabata
Aug 14, 2010·Biomacromolecules·Boce ZhangQin Wang
Aug 19, 2010·Journal of Agricultural and Food Chemistry·Lingyun ChenMuriel Subirade
Oct 21, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Christina Kriegel, Mansoor Amiji
Nov 26, 2010·International Journal of Pharmaceutics·L F Lai, H X Guo
Jan 5, 2011·Proceedings of the National Academy of Sciences of the United States of America·Piyush KoriaMartin L Yarmush
Feb 23, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ahmed O ElzoghbyNazik A Elgindy
Feb 26, 2011·Journal of Colloid and Interface Science·Laura PastorinoVictor Erokhin
Apr 8, 2011·Neoplasia : an International Journal for Oncology Research·Mian M K ShahzadAnil K Sood
Jul 19, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Andrew J SimnickAshutosh Chilkoti
Jul 21, 2011·Molecular Pharmaceutics·Giovanni Konat ZorziAlejandro Sánchez
Aug 13, 2011·Journal of Biomedical Nanotechnology·Rakesh KumarJayanta Kumar Pandit
Aug 16, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ahmed O ElzoghbyNazik A Elgindy
Sep 15, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hiroya KuwaharaTakanori Yokota

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved